Return of BioPharm America™ 2013 to Boston Will Draw Leading International Life Science Dealmakers to Northeast

BioPharm America 2013

WASHINGTON & CARLSBAD, Calif. & BOSTON--()--EBD Group, the leading partnering firm for the life science industry, in collaboration with the Massachusetts Biotechnology Council (MassBio) announced today that BioPharm America™ 2013 will again be held in Boston September 17–19 at the Westin Boston Waterfront in Boston, MA.

Senior executives from big pharma are set to attend, including AstraZeneca, Bayer HealthCare, EMD Serono, Janssen, Merck, Novo Nordisk, Shire, and more. Program topics cover trends in healthcare and drug development and other timely issues for industry insiders. Spotlight panels and roundtables will also feature industry leaders in discussions on innovative partnerships, emerging markets and global drug development strategies. The 2012 edition welcomed over 750 delegates representing 462 companies from 30 countries. Delegates in 2012 engaged in 1,846 one-to-one partnering meetings with 652 licensing opportunities.

“Boston is a biotechnology innovation hub. There are more than 500 companies focused on pharmaceutical and biotech drug discovery located in Massachusetts, from small start-ups to large established pharmaceuticals,” said Carola Schropp, President of EBD Group. “This creates an ideal environment for partnering, and is what draws the global biotech sector to BioPharm America.”

“At MassBio, our focus is to promote world class biotechnology in Massachusetts, and BioPharm America is the forum that enables regional biotech companies to identify and enter into strategic relationships at the global level,” said Robert Coughlin, President and CEO of MassBio. “The partnering at BioPharm America, and particularly the process of meeting face-to-face to discuss novel assets, is a definite advantage in the culmination of any deal.”

BioPharm America 2013 will again celebrate the announcement of the Fierce 15, selected for their pioneering technology and innovative business models, with John Carroll, Editor-in-Chief of FierceBiotech, featured on a panel with several Fierce 15 CEOs to discuss the industry outlook for the life sciences.

One-to-one networking at BioPharm America™ is powered by partneringONE®, the leading conference networking solution for the life sciences.

Register before July 19, 2013 to save USD 200 at http://www.ebdgroup.com/bpa/registration/index.php. MassBio members receive an additional USD 200 discount by adding the code ‘MassBio’ in the comments field of the online registration form.

Presenting companies should submit an application by June 28, 2013 at http://www.ebdgroup.com/bpa/presenters/index.php.

About BioPharm America 2013

BioPharm America is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®.

Additional links and information:

Follow BioPharm America 2013 on Twitter: twitter.com/ebdgroup (hashtag: #BPA13)

Notes to Editors:

Entry to BioPharm America 2013 is free to members of the press, including full access to the partnering system, sessions, press conferences, workshops, and pre-arranged partnering meetings. Visit the BioPharm America conference website at http://www.ebdgroup.com/bpa/registration/press_reg.php for press registration details. In addition, Business Wire, the official News Release Distribution and Online Press Kit service for BioPharm America™ 2013, is offering services to enhance your public relations efforts.

About MassBio

www.massbio.org

MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing the development of critical new science, technology and medicines that benefit people worldwide. Representing over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and services.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™, the fastest growing partnering event in North America
  • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
  • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
  • EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
  • Partnering for Global Impact®, a new partnering conference providing an innovative forum to partner, identify and generate social and philanthropic investment and funding opportunities

EBD Group’s sophisticated web-based partnering service, partneringONE®, is also used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences all year long. Outside of the conference format, EBD Group’s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.

EBD Group has offices in the USA and Europe.

For more information please visit www.ebdgroup.com.

Contacts

EBD Group
Erin Righetti, +1-760-930-0500
erighetti@ebdgroup.com
or
MassBio
Sarah MacDonald, +1-617-674-5115
Sarah.macdonald@massbio.org

BioPharm America(TM) 2013 in Boston (Photo: Business Wire)

???news_view.multimedia.download???

???pagination.previous??? ???pagination.next???

Release Summary

BioPharm America™ 2013 will be held in Boston Sept 17–19 at the Westin Boston Waterfront. Senior executives from big pharma are set to attend, including AstraZeneca, Bayer, Janssen, Merck and more.

Sharing

Contacts

EBD Group
Erin Righetti, +1-760-930-0500
erighetti@ebdgroup.com
or
MassBio
Sarah MacDonald, +1-617-674-5115
Sarah.macdonald@massbio.org